James Lu


I am proud to be a trusted advisor to our clients in handling a wide range of transactions and contingencies in today’s complex, global business environment.


+86 21 6030 0603
+1 858 550 6101

James is a co-founder of Cooley’s Shanghai office and the head of its corporate practice. James focuses on Asia-related corporate and securities transactions, including foreign direct investment, venture capital financing, private equity investments, mergers and acquisitions and public offerings. He also has broad experience advising clients on complex cross-border commercial transactions involving unique structures and contractual arrangements designed to comply with legal requirements in multiple jurisdictions, including licensing, joint venture, manufacturing and distribution arrangements in the life sciences and high-tech industries in Asia. James is a frequent speaker at local and international conferences and has spoken extensively on topics relating to Asia's venture capital and capital market environment.

Download full bio 


  • Legal 500 Asia Pacific Highlights Cooley 

  • Crown Bioscience Enters Merger Agreement With JSR Corporation 

  • EpimAb and Innovent Enter $120 Million Bispecific Antibody Partnership 

  • Johnson Controls on $7.5 Billion Joint Venture with SAIC's Yanfeng Automotive Trim Systems 


  • University of San Diego School of Law
    JD, summa cum laude, Valedictorian, Order of the Coif, Outstanding Service Award

  • University of Illinois at Urbana-Champaign
    MS, Biochemistry

  • University of Science and Technology of China
    BS, Biology

Admissions & Credentials


Registered to practice before the United States Patent & Trademark Office (USPTO)


+86 21 6030 0603 office
+1 858 550 6101 office

IFC - Tower 2, Level 35, Unit 3510
8 Century Avenue
Pudong New Area
Shanghai, China 200120

Other Offices